Trials / Unknown
UnknownNCT03572270
HIV and Ovarian Reserve
Evaluation of the Potential Impact of HIV and Its Treatments on Ovarian Reserve: Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- Female
- Age
- 18 Years – 37 Years
- Healthy volunteers
- Accepted
Summary
Recent evidence suggests a decline in fertility of persons living with HIV (PLWH) (delayed pregnancies, sponteanous abortions, especially when patients receive an antiretroviral therapy, early menopause, amenorrhea and anovulatory cycles) with a possible decrease in ovarian reserve. However, indications of fertility preservation by freezing oocytes are nevertheless not clearly identified. The objective of this study is to evaluate the ovarian reserve before and after the implementation of antiretroviral treatment in PLWH for whom the diagnosis of HIV has just been made.
Detailed description
This is a monocentric prospective cohort study with minimal risk and constraints. Ovarian reserve is compared between two groups: 30 PLWH, at time of diagnosis and 6, 12 and 18 months after initiation of an antiretroviral therapy, and 30 HIV negative women attending medically assisted procreation consultation for male infertility, age, BMI and smoking habits matched.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | AMH test | Blood test and pelvic ultrasound are performed at each visit to evaluate ovarian reserve |
| DIAGNOSTIC_TEST | pelvic ultrasound | Blood test and pelvic ultrasound are performed at each visit to evaluate ovarian reserve |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2022-06-01
- Completion
- 2022-11-01
- First posted
- 2018-06-28
- Last updated
- 2018-06-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03572270. Inclusion in this directory is not an endorsement.